Ju Yue-Kun, Huang Wenbing, Jiang Lele, Barden Julian A, Allen David G
Department of Physiology, Institute for Biomedical Research, University of Sydney, NSW, Australia.
J Physiol. 2003 Nov 1;552(Pt 3):777-87. doi: 10.1113/jphysiol.2003.052258. Epub 2003 Aug 29.
The effect of extracellular ATP (10-100 microM) on intracellular Ca2+ concentration ([Ca2+]i) and firing rate has been studied in single pacemaker cells isolated from the sinus venosus of cane toads. In spontaneously firing cells, ATP initially increased peak [Ca2+]i by 43 +/- 5 %, increased diastolic [Ca2+]i by 20 + 3 % and increased the firing rate by 58 +/- 8 %. These early effects were followed by a late phase in which both the peak [Ca2+]i and the firing rate declined. Adenosine, and UTP (respectively, P1- and P2Y2,4,6-selective agonists) caused no significant change in [Ca2+]i or firing rate, while alphabeta-methylene ATP (a P2X1,3 agonist) caused a small increase in firing rate but no changes in [Ca2+]i. In contrast the P2Y1-selective agonist 2-MesADP (1 microM) mimicked the biphasic effects of ATP and these effects were inhibited by the purinoceptor antagonists suramin and PPADS and by the P2Y1-selective antagonist MRS 2179. Immunohistochemistry established that P2Y1 purinoceptors were present on the cell surface. Western blotting analysis demonstrated that the P2Y1 antibody recognised a 57 kDa protein. After sarcoplasmic reticulum Ca2+ release was prevented with caffeine or ryanodine, ATP no longer had any effect on [Ca2+]i or firing rate. Furthermore, the SR Ca2+ store content was decreased during the late phase of 2-MesADP application. The effect of ATP was coupled to phospholipase C (PLC) activity because the PLC inhibitor U-73122 eliminated the effects of ATP. Our study shows that in toad pacemaker cells, the biphasic effects of ATP on pacemaker activity are mainly through P2Y1 purinoceptors, which are able to modulate Ca2+ release from the SR Ca2+ store.
已在从海蟾蜍静脉窦分离出的单个起搏细胞中研究了细胞外ATP(10 - 100微摩尔)对细胞内钙离子浓度([Ca2+]i)和放电频率的影响。在自发放电的细胞中,ATP最初使[Ca2+]i峰值增加43±5%,舒张期[Ca2+]i增加20 + 3%,并使放电频率增加58±8%。这些早期效应之后是一个晚期阶段,其中[Ca2+]i峰值和放电频率均下降。腺苷和UTP(分别为P1和P2Y2、4、6选择性激动剂)对[Ca2+]i或放电频率无显著影响,而αβ - 亚甲基ATP(一种P2X1、3激动剂)使放电频率略有增加,但对[Ca2+]i无影响。相比之下,P2Y1选择性激动剂2 - MesADP(1微摩尔)模拟了ATP的双相效应,并且这些效应被嘌呤受体拮抗剂苏拉明和PPADS以及P2Y1选择性拮抗剂MRS 2179抑制。免疫组织化学证实P2Y1嘌呤受体存在于细胞表面。蛋白质印迹分析表明,P2Y1抗体识别一种57 kDa的蛋白质。在用咖啡因或兰尼碱阻止肌浆网Ca2+释放后,ATP对[Ca2+]i或放电频率不再有任何影响。此外,在应用2 - MesADP的晚期阶段,肌浆网Ca2+储存含量降低。ATP的作用与磷脂酶C(PLC)活性相关,因为PLC抑制剂U - 73122消除了ATP的作用。我们的研究表明,在蟾蜍起搏细胞中,ATP对起搏活动的双相效应主要通过P2Y1嘌呤受体,该受体能够调节从肌浆网Ca2+储存中释放Ca2+。